Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_2
3
100%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (100.0%)

Trials by Status

terminated133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_2

Imaging Tau in Alzheimer's Disease and Normal Aging

NCT03373604
completedphase_2

Imaging Inflammation in Alzheimer's Disease

NCT02831283
terminatedphase_2

Imaging Tau in Alzheimer's Disease and Normal Aging

NCT02884492

Clinical Trials (3)

Showing 3 of 3 trials
NCT03373604Phase 2

Imaging Tau in Alzheimer's Disease and Normal Aging

Completed
NCT02831283Phase 2

Imaging Inflammation in Alzheimer's Disease

Completed
NCT02884492Phase 2

Imaging Tau in Alzheimer's Disease and Normal Aging

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3